| Bioactivity | FeTPPS, a 5,10,15,20-tetrakis (4-sulfonatophenyl) porphyrin iron III chloride peroxynitrite decomposition catalyst, possesses evident neuroprotective effects in a experimental model of spinal cord damage[1]. FeTPPS acts as a peroxynitrite scavenger and anti-nitrating agent in vivo. FeTPPS reduces nitric oxide (NO) production and apoptosis process[2]. | |||||||||
| Invitro | FeTPPS acts as an effective pro-oxidant towards appreciable substrates in vitro in the presence of oxidant. FeTPPS protects cells against oxidative damage induced by H2O2, generated by Glucose (G)-glucose oxidase (GO) system[2]. Cell Viability Assay[2] Cell Line: | |||||||||
| Name | FeTPPS | |||||||||
| CAS | 90384-82-0 | |||||||||
| Formula | C44H28ClFeN4O12S4 | |||||||||
| Molar Mass | 1024.27 | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
FeTPPS
CAS: 90384-82-0 F: C44H28ClFeN4O12S4 W: 1024.27
FeTPPS, a 5,10,15,20-tetrakis (4-sulfonatophenyl) porphyrin iron III chloride peroxynitrite decomposition catalyst, poss
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.